Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether
The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate.
Autor*in: |
Ricky Wayne McCullough [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2014 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: International Journal of Biomedicine - International Medical Research and Development Corporation, 2013, 4(2014), 4, Seite 194-197 |
---|---|
Übergeordnetes Werk: |
volume:4 ; year:2014 ; number:4 ; pages:194-197 |
Links: |
---|
Katalog-ID: |
DOAJ079657702 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ079657702 | ||
003 | DE-627 | ||
005 | 20230307020735.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230307s2014 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)DOAJ079657702 | ||
035 | |a (DE-599)DOAJc6dd5b4a69ee4f3c87a7fc6edbba76a2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Ricky Wayne McCullough |e verfasserin |4 aut | |
245 | 1 | 0 | |a Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate. | ||
650 | 4 | |a Mucositis; | |
650 | 4 | |a Chemoradiation; | |
650 | 4 | |a Sucralfate; | |
650 | 4 | |a Polymerized Sucralfate. | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
773 | 0 | 8 | |i In |t International Journal of Biomedicine |d International Medical Research and Development Corporation, 2013 |g 4(2014), 4, Seite 194-197 |w (DE-627)741171996 |w (DE-600)2710779-6 |x 21580529 |7 nnns |
773 | 1 | 8 | |g volume:4 |g year:2014 |g number:4 |g pages:194-197 |
856 | 4 | 0 | |u https://doaj.org/article/c6dd5b4a69ee4f3c87a7fc6edbba76a2 |z kostenfrei |
856 | 4 | 0 | |u http://ijbm.org/articles/Article4(4)_Com1.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2158-0510 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2158-0529 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 4 |j 2014 |e 4 |h 194-197 |
author_variant |
r w m rwm |
---|---|
matchkey_str |
article:21580529:2014----::uainfuoiifrogrhnt4ekadaba |
hierarchy_sort_str |
2014 |
publishDate |
2014 |
allfields |
(DE-627)DOAJ079657702 (DE-599)DOAJc6dd5b4a69ee4f3c87a7fc6edbba76a2 DE-627 ger DE-627 rakwb eng Ricky Wayne McCullough verfasserin aut Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate. Mucositis; Chemoradiation; Sucralfate; Polymerized Sucralfate. Medicine R In International Journal of Biomedicine International Medical Research and Development Corporation, 2013 4(2014), 4, Seite 194-197 (DE-627)741171996 (DE-600)2710779-6 21580529 nnns volume:4 year:2014 number:4 pages:194-197 https://doaj.org/article/c6dd5b4a69ee4f3c87a7fc6edbba76a2 kostenfrei http://ijbm.org/articles/Article4(4)_Com1.pdf kostenfrei https://doaj.org/toc/2158-0510 Journal toc kostenfrei https://doaj.org/toc/2158-0529 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2014 4 194-197 |
spelling |
(DE-627)DOAJ079657702 (DE-599)DOAJc6dd5b4a69ee4f3c87a7fc6edbba76a2 DE-627 ger DE-627 rakwb eng Ricky Wayne McCullough verfasserin aut Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate. Mucositis; Chemoradiation; Sucralfate; Polymerized Sucralfate. Medicine R In International Journal of Biomedicine International Medical Research and Development Corporation, 2013 4(2014), 4, Seite 194-197 (DE-627)741171996 (DE-600)2710779-6 21580529 nnns volume:4 year:2014 number:4 pages:194-197 https://doaj.org/article/c6dd5b4a69ee4f3c87a7fc6edbba76a2 kostenfrei http://ijbm.org/articles/Article4(4)_Com1.pdf kostenfrei https://doaj.org/toc/2158-0510 Journal toc kostenfrei https://doaj.org/toc/2158-0529 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2014 4 194-197 |
allfields_unstemmed |
(DE-627)DOAJ079657702 (DE-599)DOAJc6dd5b4a69ee4f3c87a7fc6edbba76a2 DE-627 ger DE-627 rakwb eng Ricky Wayne McCullough verfasserin aut Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate. Mucositis; Chemoradiation; Sucralfate; Polymerized Sucralfate. Medicine R In International Journal of Biomedicine International Medical Research and Development Corporation, 2013 4(2014), 4, Seite 194-197 (DE-627)741171996 (DE-600)2710779-6 21580529 nnns volume:4 year:2014 number:4 pages:194-197 https://doaj.org/article/c6dd5b4a69ee4f3c87a7fc6edbba76a2 kostenfrei http://ijbm.org/articles/Article4(4)_Com1.pdf kostenfrei https://doaj.org/toc/2158-0510 Journal toc kostenfrei https://doaj.org/toc/2158-0529 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2014 4 194-197 |
allfieldsGer |
(DE-627)DOAJ079657702 (DE-599)DOAJc6dd5b4a69ee4f3c87a7fc6edbba76a2 DE-627 ger DE-627 rakwb eng Ricky Wayne McCullough verfasserin aut Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate. Mucositis; Chemoradiation; Sucralfate; Polymerized Sucralfate. Medicine R In International Journal of Biomedicine International Medical Research and Development Corporation, 2013 4(2014), 4, Seite 194-197 (DE-627)741171996 (DE-600)2710779-6 21580529 nnns volume:4 year:2014 number:4 pages:194-197 https://doaj.org/article/c6dd5b4a69ee4f3c87a7fc6edbba76a2 kostenfrei http://ijbm.org/articles/Article4(4)_Com1.pdf kostenfrei https://doaj.org/toc/2158-0510 Journal toc kostenfrei https://doaj.org/toc/2158-0529 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2014 4 194-197 |
allfieldsSound |
(DE-627)DOAJ079657702 (DE-599)DOAJc6dd5b4a69ee4f3c87a7fc6edbba76a2 DE-627 ger DE-627 rakwb eng Ricky Wayne McCullough verfasserin aut Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate. Mucositis; Chemoradiation; Sucralfate; Polymerized Sucralfate. Medicine R In International Journal of Biomedicine International Medical Research and Development Corporation, 2013 4(2014), 4, Seite 194-197 (DE-627)741171996 (DE-600)2710779-6 21580529 nnns volume:4 year:2014 number:4 pages:194-197 https://doaj.org/article/c6dd5b4a69ee4f3c87a7fc6edbba76a2 kostenfrei http://ijbm.org/articles/Article4(4)_Com1.pdf kostenfrei https://doaj.org/toc/2158-0510 Journal toc kostenfrei https://doaj.org/toc/2158-0529 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2014 4 194-197 |
language |
English |
source |
In International Journal of Biomedicine 4(2014), 4, Seite 194-197 volume:4 year:2014 number:4 pages:194-197 |
sourceStr |
In International Journal of Biomedicine 4(2014), 4, Seite 194-197 volume:4 year:2014 number:4 pages:194-197 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Mucositis; Chemoradiation; Sucralfate; Polymerized Sucralfate. Medicine R |
isfreeaccess_bool |
true |
container_title |
International Journal of Biomedicine |
authorswithroles_txt_mv |
Ricky Wayne McCullough @@aut@@ |
publishDateDaySort_date |
2014-01-01T00:00:00Z |
hierarchy_top_id |
741171996 |
id |
DOAJ079657702 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ079657702</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307020735.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230307s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ079657702</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJc6dd5b4a69ee4f3c87a7fc6edbba76a2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ricky Wayne McCullough</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mucositis;</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemoradiation;</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sucralfate;</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Polymerized Sucralfate.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International Journal of Biomedicine</subfield><subfield code="d">International Medical Research and Development Corporation, 2013</subfield><subfield code="g">4(2014), 4, Seite 194-197</subfield><subfield code="w">(DE-627)741171996</subfield><subfield code="w">(DE-600)2710779-6</subfield><subfield code="x">21580529</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:194-197</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/c6dd5b4a69ee4f3c87a7fc6edbba76a2</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ijbm.org/articles/Article4(4)_Com1.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2158-0510</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2158-0529</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">2014</subfield><subfield code="e">4</subfield><subfield code="h">194-197</subfield></datafield></record></collection>
|
author |
Ricky Wayne McCullough |
spellingShingle |
Ricky Wayne McCullough misc Mucositis; misc Chemoradiation; misc Sucralfate; misc Polymerized Sucralfate. misc Medicine misc R Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether |
authorStr |
Ricky Wayne McCullough |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)741171996 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut |
collection |
DOAJ |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
21580529 |
topic_title |
Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether Mucositis Chemoradiation Sucralfate Polymerized Sucralfate |
topic |
misc Mucositis; misc Chemoradiation; misc Sucralfate; misc Polymerized Sucralfate. misc Medicine misc R |
topic_unstemmed |
misc Mucositis; misc Chemoradiation; misc Sucralfate; misc Polymerized Sucralfate. misc Medicine misc R |
topic_browse |
misc Mucositis; misc Chemoradiation; misc Sucralfate; misc Polymerized Sucralfate. misc Medicine misc R |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
International Journal of Biomedicine |
hierarchy_parent_id |
741171996 |
hierarchy_top_title |
International Journal of Biomedicine |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)741171996 (DE-600)2710779-6 |
title |
Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether |
ctrlnum |
(DE-627)DOAJ079657702 (DE-599)DOAJc6dd5b4a69ee4f3c87a7fc6edbba76a2 |
title_full |
Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether |
author_sort |
Ricky Wayne McCullough |
journal |
International Journal of Biomedicine |
journalStr |
International Journal of Biomedicine |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2014 |
contenttype_str_mv |
txt |
container_start_page |
194 |
author_browse |
Ricky Wayne McCullough |
container_volume |
4 |
format_se |
Elektronische Aufsätze |
author-letter |
Ricky Wayne McCullough |
title_sort |
duration of mucositis: far longer than 2 to 4 weeks and may be avoidable altogether |
title_auth |
Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether |
abstract |
The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate. |
abstractGer |
The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate. |
abstract_unstemmed |
The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
4 |
title_short |
Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether |
url |
https://doaj.org/article/c6dd5b4a69ee4f3c87a7fc6edbba76a2 http://ijbm.org/articles/Article4(4)_Com1.pdf https://doaj.org/toc/2158-0510 https://doaj.org/toc/2158-0529 |
remote_bool |
true |
ppnlink |
741171996 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
up_date |
2024-07-04T00:21:01.464Z |
_version_ |
1803605729833123840 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ079657702</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307020735.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230307s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ079657702</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJc6dd5b4a69ee4f3c87a7fc6edbba76a2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ricky Wayne McCullough</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Duration of Mucositis: Far Longer Than 2 to 4 Weeks and May Be Avoidable Altogether</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The impression oral mucositis is a brief consequence of chemoradiation is misguided. Patient-reported clinically significant oral mucositis may last 46 to 102 days depending on the cancer treatment, and may possibly be avoided with polymerized cross-linked sucralfate.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mucositis;</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemoradiation;</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sucralfate;</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Polymerized Sucralfate.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International Journal of Biomedicine</subfield><subfield code="d">International Medical Research and Development Corporation, 2013</subfield><subfield code="g">4(2014), 4, Seite 194-197</subfield><subfield code="w">(DE-627)741171996</subfield><subfield code="w">(DE-600)2710779-6</subfield><subfield code="x">21580529</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:194-197</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/c6dd5b4a69ee4f3c87a7fc6edbba76a2</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ijbm.org/articles/Article4(4)_Com1.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2158-0510</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2158-0529</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">2014</subfield><subfield code="e">4</subfield><subfield code="h">194-197</subfield></datafield></record></collection>
|
score |
7.398837 |